biopharmaceutical
Junshi Becomes First Dual-listed Biopharma Firm After $692m STAR IPO
Business - Published date: .
Junshi Biosciences has become the first Chinese biopharmaceutical company to float shares on both the mainland and Hong... Read more
Hillhouse-backed Genor Biopharma Files For $320m HK IPO
Business - Published date: .
Hillhouse-backed Chinese biopharmaceutical firm JHBP (CY) Holdings Limited, also known as Genor Biopharma, has filed fo... Read more
Chinese Oncology Drug Developer Tot Biopharm Raises $75.2m In HK IPO
Business - Published date: .
Tot Biopharm, a Chinese clinical-stage biopharma firm specialized in innovative oncology drugs and therapies, has raise... Read more